<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu XM</submitter><funding>Howard Hughes Medical Institute</funding><funding>Basic Research Program of Jiangsu Province</funding><funding>Foundation for the National Institutes of Health</funding><funding>National Natural Science Foundation of China</funding><funding>NCI NIH HHS</funding><pagination>559</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11803071</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>79(11)</volume><pubmed_abstract>Transcriptional programming plays a key role in determining the cell state. Timely reconfiguration of chromatin structure and attenuation of pluripotent genes are required for efficient embryonic stem cell (ESC) differentiation. Here, we identify METTL3, a core N&lt;sup>6&lt;/sup>-methyladenosine (m&lt;sup>6&lt;/sup>A) catalyzing enzyme, as a crucial modulator of dynamic transcription and chromatin accessibility upon ESC-derived cardiac differentiation. Genome-wide analysis of chromatin-associated RNAs revealed that depletion of METTL3 failed to dramatically attenuate the transcription of pluripotent genes, as well as activate nascent cardiomyocyte-specific transcripts upon differentiation. Consistently, ATAC-seq analysis showed that loss of METTL3 markedly attenuated the dynamic alteration of chromat</pubmed_abstract><journal>Cellular and molecular life sciences : CMLS</journal><pubmed_title>METTL3 modulates chromatin and transcription dynamics during cell fate transition.</pubmed_title><pmcid>PMC11803071</pmcid><funding_grant_id>BK20211219</funding_grant_id><funding_grant_id>R21CA227917</funding_grant_id><funding_grant_id>32070868</funding_grant_id><funding_grant_id>55108556</funding_grant_id><funding_grant_id>R21 CA227917</funding_grant_id><funding_grant_id>81974527</funding_grant_id><funding_grant_id>BK20190533</funding_grant_id><pubmed_authors>Liu XM</pubmed_authors><pubmed_authors>Qian SB</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Mao Y</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors></additional><is_claimable>false</is_claimable><name>METTL3 modulates chromatin and transcription dynamics during cell fate transition.</name><description>Transcriptional programming plays a key role in determining the cell state. Timely reconfiguration of chromatin structure and attenuation of pluripotent genes are required for efficient embryonic stem cell (ESC) differentiation. Here, we identify METTL3, a core N&lt;sup>6&lt;/sup>-methyladenosine (m&lt;sup>6&lt;/sup>A) catalyzing enzyme, as a crucial modulator of dynamic transcription and chromatin accessibility upon ESC-derived cardiac differentiation. Genome-wide analysis of chromatin-associated RNAs revealed that depletion of METTL3 failed to dramatically attenuate the transcription of pluripotent genes, as well as activate nascent cardiomyocyte-specific transcripts upon differentiation. Consistently, ATAC-seq analysis showed that loss of METTL3 markedly attenuated the dynamic alteration of chromat</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-04T01:35:59.526Z</modification><creation>2025-04-04T01:35:59.526Z</creation></dates><accession>S-EPMC11803071</accession><cross_references><pubmed>36266520</pubmed><doi>10.1007/s00018-022-04590-x</doi></cross_references></HashMap>